Clinical and biological features associate with migraine treatment responses. Research that validates and expands upon existing findings in clinical settings is needed to achieve precision medicine for migraine treatment. Precision medicine for migraine aims to tailor treatments

Trigeminal Nevralji nedir? "Yüzde aniden hissedilen keskin, elektrik çarpması gibi bir ağrı mı yaşıyorsunuz? Bu Trigeminal Nevralji olabilir. Yüz sinirini etkileyen bu ağrıya dikkat edelim! #TrigeminalNevralji #FarkındalıkGünü #MigraineAndPain"

Trigeminal Nevralji'nin Gizli Yüzü "Trigeminal Nevralji, görünmeyen ama hayatı zorlaştıran bir hastalık. Sessizce yaşayanların sesine kulak verelim. #GörünmeyenAğrı #TrigeminalNevralji # TürkDişHekimleriBirliği

Today is Trigeminal Neuralgia Awareness Day! #TrigeminalNeuralgia is characterized by recurrent, brief electric shock-like pains on one side of the face, triggered by innocuous stimuli. Let’s come together to raise awareness and support those enduring this condition. Together,

Trigeminal Nevralji nedir? youtu.be/2NwEHcPtdMA?si… YouTube aracılığıyla. International Headache Society globalmigrainepain Elif Ilgaz

Trigeminal Nevralji nasıl teşhis edilir? youtu.be/qNN6D00Ml7U?si… YouTube aracılığıyla International Headache Society globalmigrainepain @elifkocasoyorhan

Trigeminal Nevralji nasıl tedavi edilir? youtu.be/SHzJdeX1o9g?si… YouTube aracılığıyla International Headache Society globalmigrainepain Hamit Genç

Today in Istanbul at Acibadem University. globalmigraine-pain.com

🎉 The IHS Child and Adolescent Committee Webinar recording is now available on the IHS Learning Centre! Hear from Dr. Mona Nada, Dr. Pinar Topaloğlu, and Dr. Aynur Özge on migraine prevention, device treatments, and behavioral approaches for young patients. #NeuroTwitter

Save the date! Join us for the International Headache Congress 2025 in São Paulo, 10-13 September! For the first time in Latin America, over 100 experts from 30+ countries will share groundbreaking advances in headache care. Don’t miss this unique scientific and cultural

IHC 2025: Making History in Latin America! Join us in São Paulo, 10–13 September 2025, for a groundbreaking event dedicated to the future of global headache care. #SaveTheDate #IHC2025 #headache

🎉✨ Celebrating Our Exceptional Peer Reviewers for Cephalalgia On behalf of the entire Cephalalgia journal team, we extend our deepest gratitude and heartfelt congratulations to our exceptional peer reviewers for their invaluable contributions: Gregory Dussor (U.S.A.) David

Healthcare Professionals play a vital role in tension-type headache advocacy and awareness efforts. #TTHAwareness #HeadacheHealth #TTH2025 The video in Turkish can be viewed on the IHS YouTube channel. Gerilim Tipi Başağrısı Nedir? youtube.com/watch?v=Psvyfy…

globalmigrainepain aynurozge Prof. Dr. Derya Uludüz #TTHAwareness #HeadacheHealth #TTH2025 Gerilim Tipi Başağrısını Nasıl Teşhis Ederiz? youtube.com/watch?v=gs2Dzt…

globalmigrainepain aynurozge Prof. Dr. Derya Uludüz globalmigrainepain International Headache Society aynurozge Prof. Dr. Derya Uludüz #TTHAwareness #HeadacheHealth #TTH2025 Gerilim Tipi Başağrısını Nasıl Tedavi Ederiz? youtube.com/watch?v=wB-3mQ…

February 14 is TTH Awareness Day! Episodic tension-type headache occurs <15 days/month, is typically bilateral, pressing or tightening, mild to moderate, and lasts 30 minutes to 7 days. It does not worsen with routine activity or cause nausea, though photophobia or phonophobia

zoom.us/j/97746123919?… Let’s talk about Neuro- Behcet disease. globalmigrainepain NÖROM

🕒 Super Early Bird Registration Ends Soon – Don’t Miss This Scientific Milestone! The 22nd International Headache Congress (IHC 2025) will bring groundbreaking advancements in headache medicine, featuring: ✅ Latest research on pathophysiology & biomarkers ✅ Innovative

June is Migraine Awareness Month Migraine is a debilitating neurological disorder that affects over 1 billion people worldwide, with 14–15% of the global population experiencing it. Women are two to three times more likely to be affected, often due to hormonal influences. This

Migraine is a debilitating neurological disorder affecting over 1 billion people, about 14–15% of the global population. Women are three times more likely to be affected, highlighting a major gender disparity. In this Episode 1 'Pain & Prejudice', Anette shares her lifelong